Views
8 years ago

Tabaco

  • Text
  • Tabaco
  • Fumar
  • Tabaquismo
  • Nicotina
  • Consumo
  • Dejar
  • Sustancias
  • Fumadores
  • Serebrisky
  • Salud
Trastornos por sustancias - Tabaco

E Bruguera Cortada, GN

E Bruguera Cortada, GN Rifà // Tabaquismo y patología psiquiátrica • Himelhoch, S., Leith, J., Goldberg, R., Kreyenbuhl, J., Medoff, D., & Dixon, L. (2009). Care and management of cardiovascular risk factors among individuals with schizophrenia and type 2 diabetes who smoke. General Hospital Psychiatry, 31(1), 30–32. • Hughes, J. R. (2008). Smoking and suicide: a brief overview. Drug and Alcohol Dependence, 98(3), 169–178. • Hughes, J. R. (2013). An updated algorithm for choosing among smoking cessation treatments. Journal of Substance Abuse Treatment, 45(2), 215–21. • Kalman, D., Morissette, S. B., & George, T. P. (2005). Co-Morbidity of Smoking in Patients with Psychiatric and Substance Use Disorders. Am J Addict, 14(2), 106–123. • Kendler, K. S., Neale, M. C., MacLean, C. J., Heath, A. C., Eaves, L. J., & Kessler, R. C. (1993). Smoking and major depression. A causal analysis. Archives of General Psychiatry, 50(1), 36–43. • Khantzian, E. J. (1985). The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. The American Journal of Psychiatry, 142(11), 1259–64. • Khantzian, E. J. (1997). The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harvard Review of Psychiatry, 4(5), 231–244. • Khantzian, E. J. (2013). Addiction as a self-regulation disorder and the role of self-medication. Addiction. 4. • Kreinin, A., Novitski, D., Rabinowitz, D., Weizman, A., & Grinshpoon, A. (2012). Association between tobacco smoking and bipolar affective disorder: Clinical, epidemiological, cross-sectional, retrospective study in outpatients. Comprehensive Psychiatry, 53(3), 269–274. • Kumari, V., & Postma, P. (2005). Nicotine use in schizophrenia: The self medication hypotheses. Neuroscience and Biobehavioral Reviews. • Lader, D., & Goddard, E. (2004). Smoking-related Behaviour and Attitudes, 2004. London. • Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000). Smoking and mental illness: A population-based prevalence study. JAMA: The Journal of the American Medical Association, 284(20), 2606–2610. • Manzella, F., Maloney, S., & Taylor, G. (2015). Smoking in schizophrenic patients: A critique of the self-medication hypothesis. World Journal of Psychiatry, 22(5), 35–46. • McClave, A. K., McKnight-Eily, L. R., Davis, S. P., & Dube, S. R. (2010). Smoking characteristics of adults with selected lifetime mental illnesses: results from the 2007 National Health Interview Survey. American Journal of Public Health, 100(12), 2464–72. • McCreadie, R. G. (2003). Diet, smoking and cardiovascular risk in people with schizophrenia: Descriptive study Diet, smoking and cardiovascular risk in people with schizophrenia Descriptive study. The British Journal of Psychiatry, 183, 534–539. • Meltzer, H., Gill, B., Hinds, K., & Petticrew, M. (1996). OPCS Surveys of PsychiatricMorbidity in Great Britain, Report 6: Economic activity and social functioning of residents with psychiatric disorders. London. • Miller, M., Hemenway, D., & Rimm, E. (2000). Cigarettes and suicide: a prospective study of 50,000 men. Am J Public Health, 90(5), 768–773. • Morisano, D., Bacher, I., Audrain-McGovern, J., & George, T. P. (2009). Mechanisms underlying the comorbidity of tobacco use in mental health and addictive disorders. Canadian Journal of psychiatry.Revue Canadienne de Psychiatrie, 54(6), 356–367. • Office on Smoking and Health. (1994). Preventing Tobacco Use Among Young People: A Report of the Surgeon General. Atlanta, GA. • Practice guideline for the treatment of patients with nicotine dependence. American Psychiatric Association. (1996). The American Journal of Psychiatry, 153(10 Suppl), 1–31. • Practice guideline for the treatment of patients with substance use disorders. (2006). American Psychiatric Association. Washington DC. • Pratt, L. A., & Brody, D. J. (2010). Depression and smoking in the U.S. household population aged 20 and over, 2005- 2008. NCHS Data Brief, (34), 1–8. • Prochaska, J. J., Fletcher, L., Hall, S. E., & Hall, S. M. (2006). Return to smoking following a smoke-free psychiatric hospitalization. The American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions, 15(1), 15–22. • Prochaska, J. J., Gill, P., & Hall, S. M. (2004). Treatment of tobacco use in an inpatient psychiatric setting. Psychiatric Services (Washington, D.C.), 55(11), 1265–1270. EDITORIAL SCIENS 85

D Serebrisky // Trastornos por sustancias - Tabaco • Prochaska, J. J., Hall, S. E., & Hall, S. M. (2009). Stage-tailored tobacco cessation treatment in inpatient psychiatry. Psychiatric Services (Washington, D.C.), 60(6), 848. • Prochaska, J. J., Rossi, J. S., Redding, C. A., Rosen, A. B., Tsoh, J. Y., Humfleet, G. L., … Hall, S. M. (2004). Depressed smokers and stage of change: implications for treatment interventions. Drug and Alcohol Dependence, 76(2), 143–51. • Royal College of Physicians. (2013). Smoking and mental health. London. • Rüther, T., Bobes, J., De Hert, M., Svensson, T. H., Mann, K., Batra, a, … Möller, H. J. (2014). EPA Guidance on tobacco dependence and strategies for smoking cessation in people with mental illness. European Psychiatry: The Journal of the Association of European Psychiatrists, 29(2), 65–82. • Schroeder, S. a, & Morris, C. D. (2010). Confronting a neglected epidemic: tobacco cessation for persons with mental illnesses and substance abuse problems. Annual Review of Public Health, 31, 297–314 1p following 314. • Siru, R., Hulse, G. K., & Tait, R. J. (2009). Assessing motivation to quit smoking in people with mental illness: a review. Addiction (Abingdon, England), 104(5), 719–33. • Taylor, G., McNeill, A., Girling, A., Farley, A., Lindson-Hawley, N., & Aveyard, P. (2014). Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ (Clinical Research Ed.), 348(feb13 1), g1151. • Taylor, T., Lader, D., Bryant, A., Keyse, L., & Joloza, M. (2006). Smoking-related behaviour and attitudes, 2005. London. • The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. (2014). Atlanta, GA. • Thomas, K. H., Martin, R. M., Knipe, D. W., Higgins, J. P. T., & Gunnell, D. (2015). Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis. BMJ, 350(mar12 8), h1109–h1109. • Williams, J. M., Anthenelli, R. M., Morris, C. D., Treadow, J., Thompson, J. R., Yunis, C., & George, T. P. (2012). A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Varenicline for Smoking Cessation in Patients With Schizophrenia or Schizoaffective Disorder. The Journal of Clinical Psychiatry. • Ziedonis, D., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., … Riley, W. T. (2008). Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco, 10(12), 1691–715. 86

Biblioteca

Av. García del Río 2585 Piso 12 A - C.A.B.A
+54 11 2092 1646 | info@sciens.com.ar

Editorial Sciens, Todos los Derechos Reservados 2015